• Adare Pharma Solutions Acquires Frontida BioPharm contractpharma
    December 02, 2021
    Expands CDMO offerings to include new capabilities such as high potency compound handling and packaging services.
  • Frontida Expands Testing Capabilities contractpharma
    February 03, 2021
    ​Frontida BioPharm has launched its new Category 1 (CAT.ONE) in vitro testing and evaluation services to support development and regulatory approvals for abuse-deterrent formulations of pain management and Central Nervous System (CNS) targeted therapies.
PharmaSources Customer Service